The international sector for Active Pharmaceutical Ingredient (API) manufacturers is a complex landscape, spanning numerous locations. PRC currently dominates the manufacturing of APIs, second to India, which is a major player in both generic API distribution. European firms , particularly in nations like Germany, Switzerland, and Italy, maintain a